Stage dependent expression and tumor suppressive function of FAM134B (JK1) in colon cancer

Molecular Carcinogenesis

Volumn 56, Issue 1, 2017, Pages 238-249

  Islam, Farhadul ^a   Gopalan, Vinod ^a   Wahab, Riajul ^a   Smith, Robert A ^a   Qiao, Bin ^b   Lam, Alfred King Yin ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

colon cancer marker; FAM134B; JK1; prognostic marker; tumor suppressor

Indexed keywords

FAMILY WITH SEQUENCE SIMILARITY 134 MEMBER B PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; FAM134B PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STAGING; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; XENOTRANSPLANTATION; ANIMAL; APOPTOSIS; COLON; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, SCID; NEOPLASM PROTEINS;

EID: 84964587675     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22488     Document Type: Article

References (25)

1. Tang WK, Chui CH, Fatima S, et al. Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma. Int J Mol Med 2007; 19:915–923.
2. Kurth I, Pamminger T, Hennings JC, et al. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet 2009; 41:1179–1181.
3. Ilgaz Aydinlar E, Rolfs A, Serteser M, Parman Y. Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family. Muscle Nerve 2014; 49:774–775.
4. Murphy SM, Davidson GL, Brandner S, Houlden H, Reilly MM. Mutation in FAM134B causing severe hereditary sensory neuropathy. J Neurol Neurosurg Psychiatry 2012; 83:119–120.
5. Kong M, Kim Y, Lee C. A strong synergistic epistasis between FAM134B and TNFRSF19 on the susceptibility to vascular dementia. Psychiatr Genet 2011; 21:37–41.
6. Melchiotti R, Puan KJ, Andiappan AK, et al. Genetic analysis of an allergic rhinitis cohort reveals an intercellular epistasis between FAM134B and CD39. BMC Med Genet 2014; 15:73.
7. Scheubert L, Schmidt R, Repsilber D, Lustrek M, Fuellen G. Learning biomarkers of pluripotent stem cells in mouse. DNA Res 2011; 18:233–251.
8. Khaminets A, Heinrich T, Mari M, et al. Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 2015; 522:354–358.
9. Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK. FAM134B (FAM134B) gene and colorectal cancer: A pilot study on the gene copy number alterations and correlations with clinicopathological parameters. Exp Mol Pathol 2014; 97:31–36.
10. Kasem K, Sullivan E, Gopalan V, Salajegheh A, Smith RA, Lam AK. FAM134B (FAM134B) represses cell migration in colon cancer: A functional study of a novel gene. Exp Mol Pathol 2014; 97:99–104.
11. Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK. The roles of JK-1 (FAM134B) expressions in colorectal cancer. Exp Cell Res 2014; 326:166–173.
12. Alqurashi N, Gopalan V, Smith RA, Lam AK. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Hum Pathol 2013; 44:2089–2096.
13. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976; 36:4562–4569.
14. Jiang H, Tang Y, Garg HK, et al. Concentration- and stage-specific effects of nitrite on colon cancer cell lines. Nitric Oxide 2012; 26:267–273.
15. Baker AM, Cox TR, Bird D, et al. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J Natl Cancer Inst 2011; 103:407–424.
16. Gopalan V, Smith RA, Lam AK. Downregulation of microRNA-498 in colorectal cancers and its cellular effects. Exp Cell Res 2015; 330:423–428.
17. Gopalan V, Pillai S, Ebrahimi F, et al. Regulation of microRNA-1288 in colorectal cancer: Altered expression and its clinicopathological significance. Mol Carcinog 2014; 53:E36–E44.
18. Rasband WS, ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997–2014.
19. Islam F, Khanam JA, Khatun M, et al. A p-menth-1-ene-4,7-diol (EC-1) from Eucalyptus camaldulensis Dhnh. Triggers apoptosis and cell cycle changes in ehrlich ascites carcinoma cells. Phytother Res 2015; 29:573–781.
20. Yu VZ, Wong VC, Dai W, et al. Nuclear localization of DNAJB6 is associated with survival of patients with esophageal cancer and reduces AKT signaling and proliferation of cancer cells. Gastroenterology 2015; 149:1825–1836.
21. Feki A, Jefford CE, Durand P, et al. BARD1 expression during spermatogenesis is associated with apoptosis and hormonally regulated. Biol Reprod 2004; 71:1614–1624.
22. Fan S, Ramalingam SS, Kauh J, Xu Z, Khuri FR, Sun SY. Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues. Cancer Biol Ther 2009; 8:1463–1469.
23. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999; 59:4083–4089.
24. Packer LM, Williams SJ, Callaghan S, Gotley DC, McGuckin MA. Expression of the cell surface mucin gene family in adenocarcinomas. Int J Oncol 2004; 25:1119–1126.
25. Yang S, Liu L, Xu P, Yang Z. MKL1 inhibits cell cycle progression through p21 in podocytes. BMC Mol Biol 2015; 16:1.